Cargando…
Relapsed/Refractory Mantle Cell Lymphoma: Beyond BTK Inhibitors
Mantle cell lymphoma (MCL) is a rare mature B-cell non-Hodgkin lymphoma (B-NHL) with historically poor outcomes. Virtually all patients will eventually experience refractory or relapsed (R/R) disease, with a virulent course of resistance and serial relapses, making treatment challenging. The availab...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954159/ https://www.ncbi.nlm.nih.gov/pubmed/35330376 http://dx.doi.org/10.3390/jpm12030376 |